Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, ...

The term "October slide" refers to a trend in which many in the chronic illness community face health setbacks, writes ...

Long-term treatment with Tyvaso DPI is safe and effective in adults with PAH who were previously on Tyvaso, according to ...

The strategy begins with medications, followed by balloon pulmonary angioplasty, and pulmonary endarterectomy surgery, a ...

Experimental treatment ALG-801 was shown to be more effective than approved PAH therapies at reducing signs of disease in an ...

Worldwide, pulmonary arterial hypertension affects more than 2 of every 100,000 women and girls of childbearing age, a new ...

Stem cell-derived conditioned medium, or the liquid that remains after cells are cultured, reduces the signs of pulmonary arterial hypertension (PAH) in rat and cell models, a study showed. “These ...

Gossamer Bio is moving toward acquiring Respira Therapeutics and its lead treatment candidate, RT234, an inhaled therapy being developed for the on-demand treatment of pulmonary hypertension (PH). The ...

As someone living with pulmonary hypertension (PH), I am dedicated to advocating for the needs of the rare disease community. My advocacy efforts span various platforms: patients, healthcare ...

Like many parents in the 1990s, my mom and dad opted to have my siblings and me regularly vaccinated according to the recommended schedule. I’m not sure they thought twice about it. This was common ...

For pregnant women with pulmonary hypertension (PH), higher pulmonary arterial pressure — blood pressure levels in the blood vessels that supply the lungs — is associated with longer hospital stays ...